Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2012

View Archived Issues

Intravaginal ring technology gains attention for HIV prevention / News in Context

Almirall describes novel SYK inhibitors at ongoing ACS meeting

In-fiber method allows scalable production of uniform structured spheres for drug delivery

FDA grants orphan drug status to mondoBIOTECH product

Dainippon Sumitomo Pharma establishes new oncology institute

New sildenafil formulation launched in Korea to treat erectile dysfunction

Abbott to launch next-generation drug-eluting stent

Pivotal BEMA-buprenorphine/naloxone trial advances

Treatment begins in trial of JVS-100 for late-stage heart failure

Gilead Sciences presents new candidate therapeutics for hepatitis

Novartis divulges new glutamate receptor antagonists

New cathepsin A inhibitors patented by Sanofi

Collaboration yields novel prostanoid EP1 receptor antagonists

Proximagen discloses novel PAR2 receptor antagonists

Novel prostanoid FP receptor agonists designed in Japan

Investigational BCR-ABL inhibitor enters new phase I/II trial in Japan

Novel IL-17A/IL-17F inhibitors identified at 4SC

New mutation linked to persistent hyperplasia of the primary vitreous

FDA requests additional information for MoxDuo NDA

U.S. university and Novartis launch exclusive licensing agreement

Alligator Bioscience enters agreement with biotech company

Inspiration Biopharmaceuticals and Ipsen restructure strategic alliance

Travoprost punctum plug for glaucoma advances to phase II

New lotion against head lice launched in U.S.

FDA approves new dosages of sublingual film for opioid dependence

Kineta clear to move first K(V)1.3 channel-specific antagonist into clinic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...